Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer.
Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer.
复制标题
癌症相关成纤维细胞衍生的外泌体 microRNA-20a 抑制 PTEN/PI3K-AKT 通路,促进非小细胞肺癌的进展和化疗耐药
DOI:
10.1002/ctm2.989
复制
发表时间:
2022-07
影响因子:
10.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Cancer‐associated fibroblasts (CAFs) contributes to overall tumor progression. In the current survey, we explored the ability of microRNA‐20a (miR‐20a) within these CAF‐derived exosomes to influence non‐small‐cell lung cancer (NSCLC) progression. Normal tissue‐associated fibroblasts (NAFs) and CAFs were collected from samples of NSCLC patient tumors and paracancerous lung tissues. Exosomes derived from these cells were then characterized via Western blotting, nanoparticle tracking analyses, and transmission electron microscopy. The expression of miR‐20a was assessed via qPCR and fluorescence in situ hybridization (FISH). CCK‐8, EdU uptake, and colony formation assessments were used for evaluating tumor proliferation, while Hoechst staining was performed to monitor the in vitro apoptotic death of tumor cells. A model of xenograft tumor established in nude mice was also used to evaluate in vivo tumor responses. CAF‐derived exosomes exhibited miR‐20a upregulation and promoted NSCLC cell proliferation and resistance to cisplatin (DDP). Mechanistically, CAF‐derived exosomes were discovered to transmit miR‐20a to tumor cells wherein it was able to target PTEN to enhance DDP resistance and proliferation. Associated PTEN downregulation following exosome‐derived miR‐20a treatment enhanced PI3K/AKT pathway activation. The achieved outcomes explain that CAFs can release miR‐20a‐containing exosomes capable of promoting NSCLC progression and chemoresistance, highlighting this pathway as a possible therapeutic target in NSCLC. CAFs‐derived exosomal miR‐20a promotes the progression of NSCLC. CAFs‐derived exosomal miR‐20a promotes chemoresistance of NSCLC. PTEN is a target gene of miR‐20a. 4. miRNA‐20a suppresses the PTEN/PI3K‐AKT pathway.
登录
查看更多内容
DOI:
10.1016/j.jconrel.2015.07.030
发表时间:
2015-12-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Batrakova EV;Kim MS
通讯作者:
Kim MS
影响因子:
3.7
作者:
Lange T;Stracke S;Rettig R;Lendeckel U;Kuhn J;Schlüter R;Rippe V;Endlich K;Endlich N
通讯作者:
Endlich N
影响因子:
14.9
作者:
Chen C;Ridzon DA;Broomer AJ;Zhou Z;Lee DH;Nguyen JT;Barbisin M;Xu NL;Mahuvakar VR;Andersen MR;Lao KQ;Livak KJ;Guegler KJ
通讯作者:
Guegler KJ
DOI:
10.1186/s13046-020-01718-4
发表时间:
2020-10-08
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Li J;Ye D;Shen P;Liu X;Zhou P;Zhu G;Xu Y;Fu Y;Li X;Sun J;Xu J;Zhang Q
通讯作者:
Zhang Q
影响因子:
14.8
作者:
Huang, Da Wei;Sherman, Brad T.;Lempicki, Richard A.
通讯作者:
Lempicki, Richard A.